Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
120,736,011
-
Share change
-
+1,619,625
-
Total reported value
-
$3,673,847,924
-
Put/Call ratio
-
192%
-
Price per share
-
$30.43
-
Number of holders
-
313
-
Value change
-
+$47,440,866
-
Number of buys
-
141
-
Number of sells
-
143
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2021
As of 31 Dec 2021,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
313 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
120,736,011 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Bellevue Group AG, BlackRock Inc., ARK Investment Management LLC, Clearbridge Investments, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and FIRST TRUST ADVISORS LP.
This page lists
316
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.